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http:WHAT THIS PAPER ADDS
To the authors knowledge this is the largest study in the literature on fenestrated/branched endografting for
patients with extensive post-dissection TAAA. The study demonstrates that fenestrated/branched endografting is
feasible and may become a promising alternative in the treatment of this complex type of pathology.Objectives: Fenestrated/branched thoracic endovascular repair (F/Br-TEVAR) is increasingly applied for
atherosclerotic thoracoabdominal aortic aneurysm (TAAA); however, use in post-dissection TAAAs is still very
limited. Experience with F/Br-TEVAR in the treatment of post-dissection TAAA is presented.
Methods: Data were analysed from prospectively maintained databases including all patients with post-
dissection TAAAs that underwent F/Br-TEVAR within the period January 2010 to July 2013 in two vascular
institutions. Evaluated outcomes included initial technical success, operative mortality and morbidity, late
survival, endoleak, aneurysm diameter regression, renal function, and reintervention during follow-up (FU).
Results: A total of 31 patients (25 male, mean age 65  11.4 years) were treated. Technical success was 93.5%
and 30-day mortality 9.6%. Temporary spinal cord ischaemia occurred in four (12.6%) patients, with no case of
permanent paraplegia. Mean FU was 17.0  10 months. There were seven late deaths, all aneurysm unrelated.
Estimated overall survival rates were 83.9  6.7, 76.4  7.9 and 71.6  8.7% at 6, 12, and 18 months,
respectively. Impairment of renal function occurred in two (6.4%) patients. Endoleaks were diagnosed in 12
patients during FU, including six type IB endoleaks and six type II endoleaks. Reintervention was required in
seven (22.5%) patients. Mean aneurysm sac regression was 9.3  8.7 mm, with a false lumen thrombosis rate of
66.7% and 88.2% for patients with a FU longer than 6 and 12 months respectively.
Conclusions: F/Br-EVAR is feasible for patients with a post-dissection TAAA. Although associated with additional
technical challenges, and a signiﬁcant need for reintervention, it leads to favourable aneurysm morphologic
changes, and may play a more prominent role in the future for this type of pathology if long-term results conﬁrm
the good initial outcome.
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A large proportion of patients suffering acute aortic
dissection will develop a post-dissection aneurysm,
regardless of type and treatment in the acute setting.1,2
This long degenerative process is characterized by exten-
sive remodelling of the aorta and increasing ﬁbrotic stiff-
ness of the intimal ﬂap, resulting in an aneurysm with
speciﬁc technical challenges. Open thoracoabdominal
aneurysm (TAAA) repair is very demanding and associatedrresponding author. P. Kasprzak, Department of Surgery, Division of
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//dx.doi.org/10.1016/j.ejvs.2014.07.005with high mortality and morbidity.3,4 Standard thoracic
endovascular aneurysm repair (TEVAR) can be a viable
approach for secondary aneurysms limited to the thoracic
aorta.5 However, as most post-dissection aneurysms involve
both the thoracic and abdominal aorta, complete aneurysm
exclusion is only feasible using fenestrated/branched stent-
grafts.
Fenestrated and branched TEVAR (F/Br-TEVAR) has
demonstrated favourable early and mid-term outcomes for
atherosclerotic TAAAs.6e8 However, speciﬁc literature on F/
Br-TEVAR in the treatment of patients with post-dissection
TAAAs is still sparse.9e11 Following publication of initial
clinical experience in six patients 2 years ago, extended
outcomes of the technique in 31 consecutive patients
treated with F/Br-TEVAR for post-dissection TAAAs in two
centres experienced in advanced endovascular techniques
are now presented.9
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Patient population
Prospectively maintained databases from two vascular in-
stitutions were analysed for patients who underwent elec-
tive F/Br-TEVAR for TAAA between January 2010 and July
2013. Patients with chronic thoracoabdominal aneurysmal
degeneration following Type A or Type B dissection
extending through the visceral segment were included in
the study. An aneurysm diameter of 55 mm or greater was
considered an indication for treatment. Informed consent
was obtained for all patients. The study was approved by
the appropriate ethical committees of both institutions.Operative planning
Preoperative planning was carried out using thin cut
(1.5 mm) spiral computerized tomography angiography
(CTA) from the chest to the groins on three-dimensional
(3D) workstations featuring multiplanar reconstruction
and centerline of ﬂow analysis. The physical status of all
patients was assessed preoperatively by the American So-
ciety of Anaesthesiologists (ASA) score.
All patients were treated with custom-made branched
and/or fenestrated Cook endografts based on the Zenith
system (William A. Cook Australia, Ltd., Brisbane, Australia).
A variety of endograft conﬁgurations was used. A proximal
tube graft was applied in cases of narrow true lumen
(<20 mm), designed with 10e15% oversizing to the prox-
imal thoracic aorta and distal landing zone 2e3 cm above
the ﬁrst targeted visceral artery. The next graft included the
fenestrations and/or branches. Caudally oriented side
branches were preferably used in cases of caudal vessel
take-off and adequate true lumen size (>20 mm) at the
level of the target vessel. Reinforced fenestrations were
applied in patients with small true lumens and when the
target vessel had a 90-degree take-off. In the case of
accessory renal arteries, the decision to revascularize was
determined by the diameter of the artery and the amount
of renal volume dependent on the vessel. Accessory renal
arteries with a diameter <3 mm were overstented.
Branches were secured with self-expandable Fluency stent-
grafts (C. R. Bard, Murray Hill, NJ, USA) in the ﬁrst institu-
tion. In the second institution, branches were either
secured with balloon-expandable Advanta V12 stent-grafts
(Atrium Medical Corporation-Hudson, NH, USA) or self-
expandable Fluency stent-grafts for stent-graft lengths
>8 mm. Fenestrations were secured with Advanta V12
stent-grafts. In cases of severe angulation of the target
vessel an additional SMART (Cordis, Warren, NJ, USA),
Wallstent (Boston Scientiﬁc, Natick, MA, USA) or Zilver
(William A. Cook Australia, Ltd., Brisbane, Australia) self-
expandable bare metal stent was deployed inside the
covered stent to prevent kinking.
Vessels originating from the false lumen were targeted
with fenestrations/branches. A standard catheterization
attempt was ﬁrst carried out with the support of a guiding
sheath. When unsuccessful, the back of a 0.035-inchTerumo wire (Terumo Corporation, Tokyo, Japan) or a
Rösch-Uchida set (William A. Cook Australia, Ltd., Brisbane,
Australia) for transjugular intrahepatic portosystemic shunt
(TIPS) procedures was used to perforate the dissection ﬂap.
Distal sealing was obtained below the level of the
dissection at the level of the distal abdominal aorta, the
common iliac arteries, or the external iliac artery whenever
needed.
Preservation of the left subclavian artery and pelvic cir-
culation was always targeted, to reduce the risk of para-
plegia. This was achieved by the use of carotidesubclavian
debranching or an additional fenestration for the left sub-
clavian artery and the use of an iliac bifurcation device (IBD)
in cases of common iliac artery involvement.
Endovascular procedure
In the ﬁrst institution procedures were initially carried out
in the operating room with a mobile C-Arm (OEC 9900 Elite,
General Electric Healthcare, WI, USA) and from January
2012 in a hybrid operating room with ﬁxed imaging (Allura
Xper FD20, Philips Medical Systems, Best, The Netherlands).
In the second institution all procedures were carried out in
a hybrid operating room with ﬁxed imaging (Artis Zeego,
Siemens AG, Forchheim, Germany). The main operative
technique has been described in detail previously.12 Pa-
tients were treated under general anaesthesia. Heparin-
ization was applied aiming to maintain an activated clotting
time (ACT) of 200e250 s. A spinal catheter was applied in
all cases and spinal ﬂuid was drained from the start of the
procedure until 48e72 hours after completion. For this
duration patients were routinely transferred to the inten-
sive care unit (ICU) and systolic blood pressure was kept
normal to high to increase perfusion of the spine through
the collateral circulation. Access was transfemoral with an
additional left transaxillary approach for caudally oriented
side branches.
To reduce the risk of paraplegia, a staging strategy was
tested in one of the two institutions. One of the branches
was intentionally left unsecured primarily, and a bridging
stent-graft was applied 2e4 weeks after the initial proce-
dure. This strategy was only introduced recently and in a
limited number of patients.
Technical success was deﬁned as an endovascularly
completed procedure with absence of type I or III endoleak
and patent target vessels.
Follow-up
Postoperatively, patients were evaluated with clinical and
laboratory examination prior to discharge. Follow-up (FU)
consisted of CTA at 1 month, 6 months, 12 months, and
yearly thereafter. CTAs were carried out using an arterial
and a delayed phase to determine the status of the false
lumen (patent/thrombosed) and the possible existence of
endoleak. Duplex ultrasound (DUS) was additionally applied
to assess the status of vessels targeted with fenestrations/
branches. Renal size measurements were carried out on
CTA 3D reconstruction images as well as DUS examinations.
Table 2. Previous aortic procedures and length of aortic coverage
distal to the left subclavian artery during these procedures.
Previous aortic procedures Patients N (%)
No procedure 7 (22.5)
1 procedure 9 (29.0)
2 procedures 12 (38.7)
3 procedures 3 (9.6)
Type of previous procedure
Ascending aortic repair 1 (3.2)
Ascending aortic and arch repair 6 (19.4)
Elephant trunk procedure 1 (3.2)
Frozen elephant trunk procedure 1 (3.2)
Descending aortic repair 5 (16.1)
TEVAR 21 (67.7)
Abdominal aortic repair 3 (9.6)
EVAR 4 (12.9)
Length of coverage from LSA
No coverage (no previous repair) 7 (22.5)
5e10 cm 3 (9.6)
11e15 cm 4 (12.9)
16e20 cm 10 (32.3)
>20 cm 7 (22.5)
Outcomes of Fenestrated/Branched Endografting 643Upon suspicion of a new endoleak or target vessel mal-
perfusion digital subtraction angiography (DSA) was carried
out. Serum creatinine and glomerular ﬁltration rate (GFR)
levels were monitored at each visit.
Data analysis
Data analysis was performed with SPSS for Windows
(version 20.0; SPSS Inc, Chicago, IL, USA). Variables are
presented as mean  standard deviation (SD) in the case of
normal distribution, and median plus range if data had a
skewed distribution. Statistical signiﬁcance was set at
p < .05. Patient survival and target vessel patency was
analysed using KaplaneMeier methodology.
RESULTS
Patient characteristics
A total of 31 patients (25 male, mean age 65  11.4 years)
underwent elective F/Br-TEVAR for post-dissection TAAA.
Twenty (64.5%) patients were classiﬁed as ASA III, ﬁve
(16.1%) patients as ASA II and six (19.4%) patients as ASA IV.
Patient demographics are presented in Table 1. Mean pre-
operative GFR was 58.3  15.0 mL/min/1.73 m2.
Median interval from the primary acute dissection was 31
months (range 1e176 months). In 22 (71%) patients, the
primary event was a type B dissection, in the remaining
nine (29%) patients a type A dissection. Table 2 demon-
strates the number and type of prior aortic procedures, as
well as the length of aorta covered during the initial pro-
cedure. Of the 24 patients with prior procedures 15 (62.5%)
had been treated in an acute setting while 9 (37.5%) had
been previously treated for chronic dissection.
Mean maximal aneurysm diameter at the time of F/Br-
TEVAR was 65.7  8.5 mm. In patients with no previous
proximal aortic reconstruction, the mean length of the
proximal landing zone was 43  25 mm. Two (6.4%) pa-
tients had a proximal landing zone <20 mm at the level of
the left subclavian artery, and in two (6.4%) patients the
aneurysmal degeneration reached the iliac artery bifurca-
tion. Table 3 shows aneurysm diameter, true lumen diam-
eter at the level of the celiac trunk, and the origin of all
target vessels (true or false lumen).Table 1. Patient comorbidities and prior acute events.
Comorbidity risk factor Patients N (%)
CAD 20 (64.5)
Congestive heart failure 10 (32.3)
Hypertension 27 (87)
Chronic obstructive pulmonary disease 17 (54.8)
Smoking (current or past) 22 (70.9)
Diabetes mellitus 4 (12.9)
Hypercholesterolemia 25 (80.6)
Serum Cr > 100 mmol/L 10 (32.3)
Previous stroke/transient ischaemic attack 2 (6.4)
Marfan syndrome 1 (3.2)
Acute event
Type A dissection 9 (29.0)
Type B dissection 22 (71)Operative planning and details
In all patients, composite fenestrated/branched systems
were applied. The composite system consisted of a thoracic
component followed by a tube graft containing the fenes-
trations/branches in 11 (35.4%) patients. In the remaining
20 (64.5%) patients an additional Zenith bifurcated graft
and a contralateral limb were used. Two (6.4%) patients
with common iliac artery aneurysms and extension of the
dissection into the external iliac artery were treated with
composite systems featuring a unilateral IBD. In two (6.4%)
patients with an inadequate proximal landing zone the left
subclavian artery was preserved by means of carotidesub-
clavian bypass in one patient and an additional subclavian
fenestration in the second patient.
In total 113 visceral vessels (57 renal arteries, 2 accessory
renal arteries, 31 superior mesenteric arteries and 23 celiac
arteries) were targeted, 78 with fenestrations and 35 with
downward branches. Target vessel revascularization is
demonstrated in Table 3. Target vessels were dissected
prior to F/Br-EVAR in ﬁve out of 113 cases. An additional
self-expandable bare metal stent was applied in 27 of the
113 (23.8%) targeted vessels. These were Smart stent in 11
(9.7%), Wallstent in 10 (8.8%) and Zilver stent in the
remaining six (5.3%) cases. Thirteen vessels were not tar-
geted. Eight of these vessels (5 renal arteries and 3 celiac
arteries) were primarily occluded. In one case the celiac
artery had been overstented and in one debranched to the
superior mesenteric artery in a previous external attempt to
treat the aneurysm with a standard thoracic endograft. Two
celiac arteries were severely stenosed and were over-
stented. In one case a planned surgical reimplantation of
the celiac artery onto the superior mesenteric artery (SMA)
was carried out during the procedure via an upper midline
incision because of a very sharp caudal vessel take-off with
extremely narrow true aortic lumen, which made planning
Table 3. Dissection characteristics with speciﬁcation of true lumen size at the level of the coeliac.
Patients An diam
(mm)
TL diam (mm) RRA TL/FL LRA TL/FL SMA TL/FL CA TL/FL Distal graft
1 72 11  22 Fen FL Fen TL Branch TL Occl Bifurc
2 73 15  28 Fen FL Fen TL Fen TL Sten TL Bifurc
3 64 48  64 Branch TL Branch TL Branch TL Branch TL Tube
4 68 31  38 Fen TL Fen TL Fen TL Branch TL Tube
5 67 8  21 Fen TL Fen FL Fen TL Reimpl TL Bifurc/IBD
6 71 16  27 Fen TL Fen FL Fen TL Fen TL Bifurc
7 67 38  27 Fen TL Fen TL Branch TL Occl Bifurc/IBD
8 72 15  25 Fen TL Fen TL Branch TL Branch TL Tube
9 63 12  23 Occl Fen TL Fen TL Fen TL Tube
10 63 18  35 Fen TL Fen TL Fen TL Branch TL Tube
11 70 17  50 Fen TL Fen TL Branch TL Branch TL Tube
12 68 15  22 Fen TL Fen TL Fen TL Branch TL Tube
13 55 15  20 Branch TL Occl Branch TL Occl Bifurc
14 88 17  31 Fen TL Fen TL Fen TL Branch TL Tube
15 60 11  28 Fen TL Fen TL Fen TL Branch TL Bifurc
16 75 8  27 Occl Fen TL Fen TL Sten Bifurc
17 55 25  25 Fen TL Occl Fen Debr Bifurc
18 74 8  30 Fen TL Fen TL Fen TL Fen TL Bifurc
19 68 20  20 Fen TL Fen TL Fen TL Fen TL Tube
20 55 12  20 Fen FL Branch FL Branch TL Branch TL Bifurc/IBD
21 55 12  25 Fen TL Fen FL Fen TL Fen TL Bifurc
22 81 50  70 Branch TL Branch TL Branch TL Branch TL Bifurc
23 55 35  35 Branch TL Occl Branch TL Branch TL Bifurc
24 55 12  26 Fen TL Fen TL Fen TL Fen TL Bifurc
25 58 10  22 Fen TL Fen TL Branch TL Branch TL Bifurc
26 55 13  29 Fen TL Fen TL Fen TL Fen TL Tube
27 74 9  22 Fen TL Fen TL Fen TL Overst Tube
28 67 14  30 Branch FL Fen TL Fen TL Fen TL Bifurc
29 70 10  28 Branch TL Branch FL Branch TL Branch TL Bifurc
30 60 20  30 Fen TL Fen TL Fen TL Branch TL Bifurc
31 58 25  25 Fen TL Fen TL Fen TL Fen TL Bifurc
Note. Artery is the origin of target vessels and fenestrated/branched stent-graft design. An ¼ aneurysm; Diam ¼ diameter; TL ¼ true
lumen; RRA ¼ right renal artery; FL ¼ false lumen; LRA ¼ left renal artery; SMA ¼ superior mesenteric artery; CA ¼ celiac artery;
Fen ¼ fenestration; Occl ¼ occluded; Bifurc ¼ bifurcated; Sten ¼ stenosis; Reimpl ¼ reimplantation; IBD ¼ iliac branched device;
Debr ¼ previous debranching; Overst ¼ previous overstenting.
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approach was applied in three (9.7%) patients.
The procedure was carried out under general anaesthesia
in all patients. A transaxillary approach was used in 17
(54.8%) patients. Median operative time was 320 minutes
(range 130e690 minutes) and median estimated blood loss
(EBL) 600 mL (range 100e3000 mL). Median ﬂuoroscopy
time was 66 minutes (range 24e112 minutes) and mean
iodinated contrast volume used 255  107 mL (iodine
concentration 300 mg/mL).
Technical success and operative outcome
Technical success was achieved in 29 out of 31 (93.5%)
patients. In one patient the fenestrated component was
deployed into the false lumen, resulting in acute occlusion
of the celiac and the superior mesenteric arteries. A lapa-
rotomy was carried out, followed by a prosthetic bypass
from the right iliac artery to the superior mesenteric, he-
patic, and splenic arteries. In the second patient catheter-
ization of a highly angulated left renal artery originating
from the false lumen was not feasible through femoralaccess. This patient had a stent-graft featuring a branch for
the celiac artery, which was primarily left unsecured for
paraplegia prevention. Catheterization of the left renal ar-
tery by a transbrachial approach during the second stage of
the procedure was planned.
Three early deaths occurred, accounting for a 30-day
mortality of 9.7%. The ﬁrst patient developed multiple or-
gan failure on the ﬁrst postoperative day after an un-
eventful endovascular procedure with complete exclusion
of the aneurysm and patent target vessels on the comple-
tion angiogram. Computed tomography angiography (CTA)
showed no sign of target vessel occlusion, but demon-
strated renal and intestinal microinfarction. The second
patient suffered a deterioration of cardiac function
following a technically successful procedure, ultimately
resulting in cardiac failure and death. Finally, the third case
involved the patient with the unsuccessful renal artery
catheterization. During the second procedure via a trans-
brachial approach he suffered a perforation of the left
subclavian artery, resulting in mediastinal bleeding and
death.
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Four (12.9%) suffered temporary spinal cord ischaemia with
paraparesis (n ¼ 2) or paresis of one limb (n ¼ 2). All four
patients had patent subclavian and internal iliac arteries. In
one of these patients spinal cord ischaemia occurred
despite staged treatment with a graft featuring an unse-
cured branch for paraplegia prevention. This patient
developed transient paraparesis after the second proce-
dure, which resolved with spinal cord drainage and blood
pressure regulation. All patients recovered fully until the
time of discharge. Finally, one (3.2%) patient required
temporary dialysis. This patient had previous open surgery
which had resulted in paraparesis and impaired renal
function. Renal function recovered after 6 weeks. His par-
aparesis did not worsen after the endovascular procedure.
This patient stayed in hospital for 37 days. No other case of
renal function deterioration >30% was witnessed in the
early postoperative period. Mean postoperative GFR was
55.7  15.7 mL/min/1.73 m2.
Median hospital stay was 12 days (range 7e37 days) and
median ICU stay 3 days (range 1e30) days.Follow-up
Mean FU was 17.0  10 months. Estimated overall survival
rates were 83.9  6.7, 76.4  7.9 and 71.6  8.7% at 6, 12,
and 18 months, respectively (Fig. 1). All-cause late mortality
during FU was seven patients, all aneurysm unrelated. In
three cases, patients were preoperatively classiﬁed as ASA IV.
During FU two cases of target vessel occlusion occurred.
In the ﬁrst patient the left renal artery, originally targeted
with a branch and secured with a Fluency stent-graft,
occluded at 2 months, following a deterioration of his
pre-existing congestive heart failure with prolonged hypo-
tension. The second patient had a small renal arteryFigure 1. KaplaneMeier estimate of the cumulative overall patient
survival for all-cause mortality during follow-up.originating from the false lumen, perfusing a smaller kidney.
This vessel had been targeted with a fenestration. The pa-
tient presented with an asymptomatic occlusion at 6
months. Cumulative target vessel patency at 6 months was
97.8  1.1% (Fig. 2). No other target vessel occlusion or
haemodynamically signiﬁcant stenosis was visualized on
DUS or CTA during FU. Renal function and kidney size
remained unchanged in 26 out of 28 (92.8%) patients sur-
viving the early postoperative period. In two patients, late
renal function problems occurred: The ﬁrst patient suffered
from chronic kidney disease prior to the procedure and
became dialysis dependent following occlusion of his left
renal artery. The second patient requiring temporary dialysis
after the procedure became dialysis dependent again 5
months postoperatively. Mean GFR during FU was
53.8  9.7 mL/min/1.73 m2.
Endoleaks were detected in 12 patients during FU. Type
Ib endoleaks were detected in 6 (19.3%) patients. Three
(9.6%) of these patients had a type Ib endoleak from the
distal sealing zone in the left renal artery. In one of these
patients the left renal artery was dissected prior to F/Br-
EVAR. One (3.2%) patient had distal type Ib endoleaks
from both renal arteries. These vessels were also primarily
dissected. One (3.2%) patient had distal type Ib endoleaks
from the superior mesenteric and the right renal artery. In
all patients vessels had been secured with Advanta V12
stent-grafts and with an additional self-expanding stent to
tape the dissection ﬂap in the case of primarily dissected
vessels. The sixth patient had a distal type Ib endoleak
originating from a dissected left common iliac artery. The
remaining six (19.3%) patients had type II endoleaks from
the inferior mesenteric (n ¼ 3) and lumbar (n ¼ 3) arteries.
In total, 10 patients required reintervention, including the
three patients that underwent planned staged procedures.Figure 2. KaplaneMeier estimate of the cumulative target vessel
patency during follow-up.
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Five of the six patients with a distal type Ib endoleak were
successfully treated with extension of the balloon-
expandable covered stent into the target visceral vessel
(Fig. 3). The sixth patient with a type Ib endoleak from the
left iliac artery underwent two reinterventions. The endo-
leak was initially treated with an IBD in the left internal iliac
artery. Upon persistence of the endoleak over the also
dissected internal iliac artery, the IBD was embolized and a
bypass from the ipsilateral external to the internal iliac ar-
tery was carried out. Finally, the seventh case involved a
patient with an extensive type II endoleak from a lumbar
artery who underwent embolization 6 months post-
operatively. Reintervention times are demonstrated in
Table 4.
Of the 24 patients that completed a 6-month FU, com-
plete false lumen thrombosis was noted in 16 (66.7%) pa-
tients. At 1 year, false lumen thrombosis was seen in 15 out
of 17 (88.2%) patients. Mean aneurysm sac regression
during FU was 9.3  8.7 mm. Initial sac enlargement was
noted in six of the seven patients requiring reintervention.
Successful treatment of type Ib endoleaks led to false
lumen thrombosis and sac regression. Aneurysm sac
behaviour in patients that completed a 12-month FU is
demonstrated in Table 5.Figure 3. Persistent type Ib endoleak from the left renal artery (A) over a
Atrium Advanta V12 stent-graft into the distal portion of the artery (B).
the reintervention show complete thrombosis of the false lumen andDISCUSSION
A rigorous FU is required following an acute thoracic aortic
dissection, regardless of primary treatment. In our series 24
out of 31 (77.5%) of patients had underwent one or more
previous procedures, 62.2% of patients had been treated in
the acute setting. Although this is a selected patient pop-
ulation, this could reﬂect the increased need for future
intervention as survival of patients with acute dissection
improves.
Open repair of post-dissection TAAA poses serious tech-
nical problems and signiﬁcant risk for the patient. Studies
from specialized, high-volume centres including both post-
dissection and atherosclerotic TAAAs report a 30-day mor-
tality rate of 5e8% with a paraplegia risk approaching 6e
8% after open thoracoabdominal repair.4,13,14 Renal com-
plications develop in 17e25% of patients with up to 15%
requiring haemodialysis. These results reﬂect the extensive
experience of high-volume centres. Analysis of volume-
related outcomes over a wider range of hospitals reveal
the “real-world” picture, with overall mortality reaching
22.3% and postoperative complication rates exceeding
55%.3,15
Although fenestrated and branched grafts are increas-
ingly used for atherosclerotic TAAAs, their use for post-renal side branch. The endoleak was treated by implantation of an
Computed tomography angiography prior to (C) and 1 year after (D)
aneurysm sac regression.
Table 4. Type of endoleak and reintervention time.
Endoleak type Time of reintervention
(months)
Ib LRA 7
Ib LRA 14
Ib LRA 9
Ib RRA, SMA 4
Ib RRA, LRA 2
Ib CIA 5;12
II Lumbar artery 6
LRA ¼ left renal artery; RRA ¼ right renal artery; SMA ¼ superior
mesenteric artery; CIA ¼ common iliac artery.
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to the rarity of cases and added technical complexity of F/
Br-TEVAR in chronic dissection. This series suggests that F/
Br-EVAR can be feasible in patients with post-dissection
TAAA. Technical success was high and early mortality
comparable to published results on F/Br-EVAR for non-post-
dissection TAAAs.7 Despite the signiﬁcant rate of temporary
spinal cord ischaemia, no case of permanent paraplegia was
noted. The renal complication rate was low. Target vessel
patency remained high and no aneurysm related mortality
was noted during FU. Notably, three of seven late deaths
occurred in patients preoperatively classiﬁed as ASA IV,
underlining the need for a cautious approach in patients
with severe comorbidities. To the author’s knowledge this is
the largest study in the literature on F/Br-TEVAR for pa-
tients with extensive post-dissection TAAA. Apart from the
authors previous report, there is one more paper featuring
30 patients with smaller focal (n ¼ 15) and extensive
(n ¼ 15) dissections.9,10
Despite the promising initial outcome, additional difﬁ-
culties in planning and execution of the procedure have to
be expected. Typically, the true lumen in post-dissection
TAAAs is oblique and narrow. Fenestrated devices might
therefore seem more suitable, since they require less space
for deployment than branched devices. Placing of the clock
positions on fenestrations can however be problematic, as
one should take into account the highly compressed true
lumen. Deployment of the device usually results in expan-
sion of the true lumen and subsequent rearranging of targetTable 5. Aneurysm sac behaviour in relation to thrombosis of the
false lumen in patients with a 12-month follow-up.
False lumen thrombosis Total
Yes No
Decrease
(<5 mm)
13a (76.4%) 1b (5.9%) 14 (82.3%)
Stable (5 mm
to 5 mm)
2 (11.8%) 1b (5.9%) 3 (17.6%)
Increase
(>5 mm)
0 0 0
Total 15 (88.2%) 2 (11.8%) 17 (100%)
a Five patients with initial sac expansion after F/Br-EVAR.
Following reintervention complete false lumen thrombosis and
aneurysm sac regression.
b Patients with a type II endoleak from lumbar arteries.vessel ostia. On the other hand, branches are easier to plan
and facilitate catheterization of target vessels with a sharp
take-off over a transaxillary access. In order to create
enough working space for the placement of a branched
device, a long proximal stent-graft is applied landing distally
2e3 cm above the oriﬁce of the celiac artery. Kitagawa
et al.10 propose staging the procedure for w2 months to
allow for expansion of the true lumen. In this series, pre-
conditioning of the false lumen with a proximal component
was not staged. Our strategy was to apply a moderate
oversizing of 10e15% to the proximal aorta and remodel
the true lumen only partially. Whether a more aggressive
oversizing and a staged approach might offer advantages is
a point to follow in future reports.
Another dissection-speciﬁc difﬁculty relates to visceral
branches originating from different lumina. In such cases,
catheterization of target vessels can be achieved by perfo-
rating the dissection ﬂap with a needle (e.g. TIPPS needle)
or the stiff end of a wire, in conjunction with a guiding
sheath.
The choice of landing zone can also be problematic in
post-dissection TAAA. In cases where a prior surgical or
endovascular landing zone has successfully been created
during a previous procedure, no issues with proximal seal-
ing, ﬁxation, or migration are to be expected. When this is
not the case, it is mandatory to preserve ﬂow in the sub-
clavian artery to diminish the risk of paraplegia. The same
issue arises at the level of the iliac arteries.When necessary,
the distal sealing zone should include the iliac bifurcation,
while ensuring ﬂow into the internal iliac artery by the use
of an IBD. Applying this strategy, no case of permanent
paraplegia was noted in this series. However, spinal cord
ischaemia obviously remains a consideration when carrying
out extensive endovascular thoracoabdominal repair.
Finally, the increased need for reintervention should be
noted. In two of ﬁve patients presenting with type Ib
endoleaks from visceral vessels, these were dissected prior
to F/Br-EVAR. Endoleaks occurred despite primary implan-
tation of an additional self-expanding stent into the
dissected vessel, indicating that especially when the
dissection progresses deep into a target vessel, retrograde
aneurysm perfusion through the false lumen may require
multiple procedures to treat. In the case of post-dissection
TAAAs, a longer initial sealing zone into the target vessel
seems to be mandatory than in atherosclerotic TAAAs.
Regarding type II endoleaks, these should be expected but
have a benign course and spontaneously seal over time,
similar to atherosclerotic aneurysms. Ultimately, the false
lumen thrombosis rate after reintervention was high in
patients that completed a 12-month FU, indicating that F/
Br-EVAR could be a durable treatment option for post-
dissection TAAAs.
This study has some limitations. The number of patients
and duration of FU are limited. This is a selected patient
population and a certain referral bias has to be acknowl-
edged. Finally, this study reﬂects the outcomes of two high-
volume centres for F/Br-TEVAR.
648 K. Oikonomou et al.In conclusion, F/Br-EVAR shows promising results and
could play a more prominent role in the future in patients
with post-dissection TAAA. It is nevertheless associated with
additional technical challenges and requires rigorous FU in
the light of the increased need for reinterventions. Larger
series and longer FU are needed to conﬁrm the good initial
outcome.
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